Inventor · disambiguated record
Kazuhiko Nakagawa
Also filed as: NAKAGAWA KAZUHIKO
5 granted patents·6 pending applications·8 citations·filing 1998–2020
68Inventor score
Top patents by PatentIndex Score
11 records- 0169US11873344B2Protein biomarker and uses thereofDAIICHI SANKYO CO LTD·Filed 2019·Granted Jan 16, 2024·0 cites·12 claims
- 0257US8802384B2Method or system using biomarkers for the monitoring of a treatmentARAO TOKUZO·Filed 2010·Granted Aug 12, 2014·2 cites·9 claims
- 0356US2015147326A1Protein biomarker and uses thereofDAIICHI SANKYO CO LTD·Filed 2014·Application pending·0 cites
- 0451US6630464B1Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancerUS HEALTH·Filed 1998·Granted Oct 7, 2003·6 cites·12 claims
- 0550US2017166654A1Protein biomarker and uses thereofDAIICHI SANKYO CO LTD·Filed 2016·Application pending·0 cites
- 0647US11371995B2Method for selecting individuals to be administered immune checkpoint inhibitorUNIV KINKI·Filed 2017·Granted Jun 28, 2022·0 cites·9 claims
- 0745US2021003579A1Method for assisting determination of efficacy of immune checkpoint inhibitorUNIV KYOTO·Filed 2020·Application pending·0 cites
- 0845US2004006074A1Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancerUS GOV HEALTH & HUMAN SERV·Filed 2002·Application pending·0 cites
- 0944US2019002988A1Method of using a ret fusion gene as a biomarker to select non small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1039US2020061031A1Method for treating egfr-tki-resistant non-small cell lung cancer by administration of anti-her3 antibody-drug conjugateUNIV KINKI·Filed 2018·Application pending·0 cites
- 1134US8598188B2Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancerNAKAGAWA KAZUHIKO·Filed 2010·Granted Dec 3, 2013·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Kazuhiko Nakagawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →